Author:
Eiber M.,Gärtner F.,Scheidhauer K.,Souvatzoglou M.
Publisher
Springer Berlin Heidelberg
Reference13 articles.
1. Macapinlac HA (2001) Clinical usefulness of FDG PET in differentiated thyroid cancer. J Nucl Med 42(1):77–78
2. Schlüter B, Bohuslavizki KH, Beyer W, Plotkin M, Buchert R, Clausen M (2001) Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan. J Nucl Med 42(1):71–76
3. Wang W, Macapinlac H, Larson SM, Yeh SDJ, Akhurst T, Finn RD et al (1999) [18F]-2-Fluoro-2-deoxy-d-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels. JCEM 84(7):2291–2302
4. Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26(12):1547–1552
5. Seiboth L, Van Nostrand D, Wartofsky L, Ousman Y, Jonklaas J, Butler C et al (2008) Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer. Thyroid 18(2):103–111
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献